HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray.

AbstractBACKGROUND AND OBJECTIVES:
High-resolution computed tomography (HRCT) of the chest is able to demonstrate the presence of pulmonary infiltrates in febrile neutropenic patients with normal chest X-rays. Fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) is a safe procedure for the etiological diagnosis of pulmonary infiltrates in oncohematologic patients. The objective of this study was to determine the diagnostic yield and subsequent therapeutic changes of a protected BAL (p-BAL) guided by HRCT in febrile oncohematologic patients unresponsive to broad-spectrum antibiotics with a normal chest X-ray.
DESIGN AND METHODS:
Twenty-two episodes from 20 oncohematologic patients were included: group A, 9 episodes (8 patients) with no respiratory symptoms and group B, 13 episodes (12 patients) with signs or symptoms of pulmonary infection. HRCT and p-BAL were performed in all episodes within the first 24 hours.
RESULTS:
HRCT showed abnormalities in all 22 episodes (bilateral abnormalities in 14 of the 22 episodes [64%]) and the most frequent pattern was ground-glass infiltrate (7 out of 22 episodes). An infectious agent was isolated in 12 of the 22 episodes, 5 in group A and 7 in group B with a diagnostic yield of 54%. Antimicrobial therapy was modified in 12 of the 22 episodes (54%): 5 in group A and 7 in group B. In 6 episodes, treatment was changed according to HRCT results and in the remaining 6 due to positive microbiologic results. Modifications in empirical therapy were associated with a favorable response in 44% episodes of group A and in 31% of group B.
INTERPRETATION AND CONCLUSIONS:
Oncohematologic patients with fever of unknown origin unresponsive to empirical antibiotics and with a normal chest X-ray can be candidates to undergo a HRCT. This subgroup of high-risk patients can benefit from a combined strategy consisting of BAL guided by a previous HRCT.
AuthorsE Rámila, A Sureda, R Martino, A Santamaría, T Franquet, C Puzo, J Montesinos, G Perea, J Sierra
JournalHaematologica (Haematologica) Vol. 85 Issue 9 Pg. 961-6 (Sep 2000) ISSN: 0390-6078 [Print] Italy
PMID10980635 (Publication Type: Journal Article)
Chemical References
  • Anti-Infective Agents
  • Antineoplastic Agents
Topics
  • Adolescent
  • Adult
  • Aged
  • Anti-Infective Agents (therapeutic use)
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Bronchoscopy
  • Female
  • Fever (etiology, microbiology)
  • Hematologic Neoplasms (complications, microbiology, therapy)
  • Humans
  • Male
  • Middle Aged
  • Neutropenia (chemically induced)
  • Radiography, Thoracic (methods)
  • Respiratory Tract Infections (diagnosis, diagnostic imaging, drug therapy, etiology)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: